Alberta BioEvolution 2008:
Become a Sponsor and join the evolution...Last chance
Info.Resource invite companies and organizations that want to help promote Alberta's biotechnology, medical device and healthcare
industry to join with Amgen, Davis Wright Tremaine, Fred Hutchinson Cancer Research Center, Lease Crutcher Lewis, Merck & Co.,
Perkins Coie, Ratner BioMedical, SAB Architects, Tonkon Torp, ZymoGenetics and others
in sponsoring the new Alberta BioEvolution poster.
Alberta BioEvolution depicts company technology licensing
relationships with the province's universities and non-profit research organizations -- the economic engines supporting
innovative research and development.
Alberta BioEvolution is a one-of-a-kind genealogy chart that illustrates the founding "technology origins" of
more than 40 biotechnology and medical device firms located in the province of Alberta. Sponsorships start
at just $250.
More...
|
|
Washington State Biomedical Device Summit May 15...Register today!

WBBA is collaborating with several organizations to host the 2008 Washington State Biomedical Device Summit. Focused
solely on the region’s medical device sector, the May 15 Summit will attract 200 executives from the medical device industry,
researchers, economic development professionals and media.
The event will feature a report on key findings of a study about
the sector, a panel discussion with executives from the region’s industry, the launch of the Biomedical Device Innovation
Partnership Zone, a showcase medical device products developed or being developed in Washington state and a reception.
WBBA’s partners on this effort are enterpriseSeattle, the Economic Development Council of Snohomish County, City of Bothell,
University of Washington Bothell, the Prosperity Partnership and the Washington Technology Industry Association (WTIA).
The event is Thursday, May 15 from 4 to 7 pm, at the UW Washington Bothell, WA.
More...
|
Local News...
Free News Release Posting & Archiving Service
- QLT reports initial proof-of-concept data for punctal plug delivery technology QLT Inc. announced results from a proof-of-concept trial conducted by QLT’s wholly-owned subsidiary, QLT Plug Delivery, of its punctal plug drug delivery technology. The results demonstrated that QLT’s drug elution technology was effective in controlling intraocular pressure and was well tolerated.
QLT Inc. May 12, 2008
- Lilly completes final phase of its Indianapolis Biotechnology Complex Eli Lilly and Company announced completion of the final phase of its $1 billion effort to further strengthen the company's biotechnology research and development capabilities.
Eli Lilly and Company May 12, 2008
- Forbes Medi-Tech announces completion of $3.8 million non-dilutive funding transaction Forbes Medi-Tech announced that, as part of its continuing reorganization plan, it has completed the previously announced transaction with a private investor to reorganize Forbes Medi-Tech Operations, a wholly owned subsidiary of Forbes.
Forbes Medi-Tech, Inc. May 12, 2008
- CV Technologies reports improved second quarter results CV Technologies reported fiscal 2008 second quarter sales of $10.7 million, up 36.5% from sales of $7.8 million in the same quarter last year. The net loss was $768 thousand or $0.01 of diluted net loss per share in the second quarter ended March 31, 2008.
CV Technologies Inc. May 12, 2008
- Province supports children's medical research A $12-million grant from the Province will support the groundbreaking work of the Children with Intestinal and Liver Disorders (CH.I.L.D.) Foundation to find a cure for children with intestinal and liver disorders such as Crohn’s Disease, Premier Gordon Campbell announced.
Premier of British Columbia May 12, 2008
More... | Submit News Release | National News
|